Patents by Inventor Eric Chellquist

Eric Chellquist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymorphic and amorphous salt forms of squalamine dilactate
    Patent number: 8716270
    Abstract: The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: May 6, 2014
    Assignee: OHR Pharmaceutical Inc.
    Inventors: Eric Chellquist, Mary Doubleday, Charles W. Gilbert, Xuehai Zhang, Michael McLane, Kyle Armbruster, Roy C. Levitt
  • Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
    Publication number: 20120022035
    Abstract: The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
    Type: Application
    Filed: June 23, 2011
    Publication date: January 26, 2012
    Inventors: Eric Chellquist, Mary Doubleday, Charles Gilbert, Xuehai Zhang, Michael McLane, Kyle Armbruster, Roy C. Levitt
  • Polymorphic and amorphous salt forms of squalamine dilactate
    Patent number: 7981876
    Abstract: The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: July 19, 2011
    Assignee: Ohr Pharmaceuticals, Inc.
    Inventors: Eric Chellquist, Mary Doubleday, Charles Gilbert, Xuehai Zhang, Michael McLane, Kyle Armbruster, Roy C. Levitt
  • Polymorphic and amorphous salt forms of squalamine dilactate
    Publication number: 20070010504
    Abstract: The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
    Type: Application
    Filed: April 25, 2006
    Publication date: January 11, 2007
    Inventors: Eric Chellquist, Mary Doubleday, Charles Gilbert, Xuehai Zhang, Michael McLane, Kyle Armbruster, Roy Levitt
  • Mucin synthesis inhibitors
    Publication number: 20050249675
    Abstract: The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 10, 2005
    Inventors: Hsiao-Ling Hung, Eric Chellquist, Roy Levitt, Michael McLane